Genomenon, a leading genomic intelligence company, today announced a strategic partnership with Compass Bioinformatics, integrating Genomenon's Mastermind FLEX Data into Compass Bioinformatics' ...

An international team of scientists, including from Rothamsted Research, have developed a new method to improve the accuracy of gene mapping in complex organisms—a breakthrough that could enhance ...

By reframing ovarian health as a central driver of longevity rather than just a reproductive milestone, Timeless Biotech aims to bring AI-driven insights to healthcare in a scalable way.

RNA is central to how cells function. Through the detailed study of RNA that combines molecular biology with advanced bioinformatics, Vicente ...

The prospect of a future where your medical history could be used to predict what health conditions you might face in the next two decades has been raised by the development of a new AI model. It can ...

A shared comprehensive understanding of the landscape needs to be integrated into the green economy transition to assess and improve ecological functions such as air and water quality, habitat support ...

The use of AI and machine learning in healthtech has grown by more than 40% each year, and job postings show this change ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn State has successfully created disease-resistant cacao plants using ...

“GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation,” saidSumir Bhatia, President, Lenovo ISG Asia Pacific. “With this leap in performance and ...

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that Andreea Creanga, MD, PhD, a distinguished and internationally recognized leader in maternal and perinatal ...

Bank of America Global Healthcare Conference 2025 September 25, 2025 5:45 AM EDTCompany ParticipantsJohn Gilardi - VP & Head ...

As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of progression-free survival (PFS), as shown in a validation of consensus ...